1. Lee SH, Park JS, Park CS. The search for genetic variants and epigenetics related to asthma. Allergy Asthma Immunol Res. 2011; 3:236–244.
2. Martinez FD, Vercelli D. Asthma. Lancet. 2013; 382:1360–1372.
3. Daley D, He JQ, Akhabir L, Stefanowicz D, Becker AB, Chan-Yeung M, et al. Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes. J Allergy Clin Immunol. 2012; 130:1284–1293.
4. Daley D, Lemire M, Akhabir L, Chan-Yeung M, He JQ, McDonald T, et al. Analyses of associations with asthma in four asthma population samples from Canada and Australia. Hum Genet. 2009; 125:445–459.
5. Chamberland A, Madore AM, Tremblay K, Laviolette M, Laprise C. A comparison of two sets of microarray experiments to define allergic asthma expression pattern. Exp Lung Res. 2009; 35:399–410.
6. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013; 39:1003–1018.
7. Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013; 25:469–484.
8. He Y, Peng S, Xiong W, Xu Y, Liu J. Association between polymorphism of interleukin-1 beta and interleukin-1 receptor antagonist gene and asthma risk: a meta-analysis. Scientific World Journal. 2015; 685684.
9. Peters VA, Joesting JJ, Freund GG. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav Immun. 2013; 32:1–8.
10. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 1993; 261:472–475.
11. Laprise C. The Saguenay-Lac-Saint-Jean asthma familial collection: the genetics of asthma in a young founder population. Genes Immun. 2014; 15:247–255.
12. Kauffmann F, Dizier MH, Annesi-Maesano I, Bousquet J, Charpin D, Demenais F, et al. EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-- descriptive characteristics. Clin Exp Allergy. 1999; 29:Suppl 4. 17–21.
13. Gauderman WJ. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol. 2002; 155:478–484.
14. Gauderman WJ, Morrison JM. QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies [Internet]. Los Angeles (CA): University of Southern California;2006. cited 2016 Jan 31. Available from:
http://hydra.usc.edu/gxe.
15. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004; 74:765–769.
16. Birbian N, Singh J, Jindal SK. Highly Protective association of MMP-2-1306C/T promoter polymorphism with asthma in a North Indian population: a pilot study. Allergy Asthma Immunol Res. 2014; 6:234–241.
17. Kuhn PH, Marjaux E, Imhof A, De Strooper B, Haass C, Lichtenthaler SF. Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. J Biol Chem. 2007; 282:11982–11995.
18. Vasilyev FF, Silkov AN, Sennikov SV. Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors. Cell Mol Immunol. 2015; 12:222–230.
19. Cole SL, Vassar R. BACE1 structure and function in health and Alzheimer's disease. Curr Alzheimer Res. 2008; 5:100–120.
20. Gong CY, Zhou AL, Mao JH, Hu YE, Geng JS. The role of Toll-like receptor 4 on inflammation and Aβ formation in cortex astrocytes. Sheng Li Xue Bao. 2014; 66:631–638.
21. Savenije OE, Mahachie John JM, Granell R, Kerkhof M, Dijk FN, de Jongste JC, et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol. 2014; 134:170–177.